NIH-funded research R01 grant

Improving brain stimulation techniques for treating depression

Official title: Optimized methods for measuring brain excitability in depression

Funded at Stanford University · NIH-11102105 · Data updated 2026-11-12

This study is looking to improve treatment for depression by finding better ways to measure how the brain responds to a special therapy called rTMS, so that each person's treatment can be customized for the best results.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startMay 1, 2025
Project endFebruary 28, 2030
Funding year2025
Award (this year)$784,096
NIH project number1R01MH139650-01
Project IDNIH-11102105 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with depression who may benefit from rTMS treatment.

Less likely to help

Patients who do not have a diagnosis of depression or those who have contraindications for rTMS may not benefit from this research.

What this research studies

This research focuses on enhancing the effectiveness of repetitive transcranial magnetic stimulation (rTMS) for depression by developing reliable methods to measure brain excitability. It aims to identify specific markers of prefrontal cortex activity that can guide personalized treatment approaches. By utilizing a new system called TARGET, the study will dynamically adjust stimulation parameters to optimize treatment outcomes based on individual brain responses. This could lead to more effective and tailored therapies for patients suffering from depression.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized treatments for depression, improving patient outcomes.

How similar studies have gone: Previous research has shown promise in using TMS for depression, but this approach aims to refine and enhance existing methods, making it a novel advancement in the field.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Keller, Corey J — Stanford University
  • Study coordinator: Keller, Corey J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.